北京市春立正达医疗器械股份有限公司（春立医疗，股票代码：01858）于2026年8月4日披露截至2026年7月31日的股份变动月报表。报告显示，公司已发行股份与上月相比无新增发行、购回或注销，整体股本保持稳定。
报告期内，公司注册股本合计为人民币383,568,500元。其中，H股股份数量95,140,500股，面值均为人民币1元，总额为人民币95,140,500元；A股股份数量288,428,000股，面值均为人民币1元，总额为人民币288,428,000元。H股与A股股本与上月相比未发生任何变动。截至7月底，H股无持作库存的股份，A股持作库存的股份数为1,376,851股。
公司在公告中指出，已严格遵守香港联合交易所有限公司《上市规则》及适用法律法规的相关规定，并确认所有发行、回购、注销、转让股份事宜均经公司董事会正式授权批准。
本次公告由公司秘书叶沛森签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.